Expression, purification, and characterization of RGD-mda-7, A his-tagged mda-7/IL-24 mutant protein

Journal of Immunoassay and Immunochemistry

Volumn 33, Issue 4, 2012, Pages 352-368

  Liu, Jun Jie ^a,b   Zhang, Bao Fu ^b,c   Yin, Xiao Xing ^c   Pei, Dong Sheng ^b   Yang, Zhi Xia ^b   Di, Jie Hui ^b   Chen, Fei Fei ^b   Li, Hui Zhong ^b   Xu, Wei ^c   Wu, Yong Ping ^c   Zheng, Jun Nian ^a,b,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Key Laboratory of Biological Cancer Therapy   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

antitumor; integrin V 3V 5; mda 7 il 24; mutant; RGD

Indexed keywords

ANTINEOPLASTIC AGENT; ARGINYLGLYCYLASPARTIC ACID MELANOMA DIFFERENTIATION ASSOCIATED GENE 7; GAMMA INTERFERON; IMMUNOSTIMULATING AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN MCF 7; CELL VIABILITY; DRUG EFFICACY; DRUG PURIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RENATURATION; WESTERN BLOTTING; WILD TYPE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; CLONING, MOLECULAR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IMMUNIZATION; INTEGRIN ALPHAVBETA3; INTERLEUKINS; MCF-7 CELLS; MUTATION; OLIGOPEPTIDES; RECEPTORS, VITRONECTIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84866344739     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2012.659782     Document Type: Article

References (25)

1. Jiang, H.; Lin, J. J.; Su, Z. Z.; Goldstein, N. I.; Fisher, P. B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995, 11, 2477-2486. (Pubitemid 26023815)
2. Caudell, E. G.; Mumm, J. B.; Poindexter, N.; Ekmekcioglu, S.; Mhashilkar, A. M.; Yang, X. H.; Retter, M. W.; Hill, P.; Chada, S.; Grimm, E. A. The protein product of the tumor suppressor gene, melanoma differentiation- associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J. Immunol. 2002, 168, 6041-6046. (Pubitemid 34620018)
3. Chada, S.; Sutton, R. B.; Ekmekcioglu, S.; Ellerhorst, J.; Mumm, J. B.; Leitner, W. W.; Yang, H. Y.; Sahin, A. A.; Hunt, K. K.; Fuson, K. L.; Po?̀ndexter, N.; Roth, J. A.; Ramesh, R.; Grimm, E. A.; Mhashilkar, A. M. MDA-7=IL-24 is a unique cytokine-tumor suppressor in the IL-10 family. Int. Immunopharmacol. 2004, 4, 649-667. (Pubitemid 38553886)
4. Fisher, P. B.; Gopalkrishnan, R. V.; Chada, S.; Ramesh, R.; Grimm, E. A.; Rosenfeld, M. R.; Curiel, D. T.; Dent, P. mda-7=IL-24, a novel cancer selective apoptosis inducing cytokine gene: From the laboratory into the clinic. Cancer Biol. Ther. 2003, 2, S23-S37.
5. Jiang, H.; Su, Z. Z.; Lin, J. J.; Goldstein, N. I.; Young, C. S.; Fisher, P. B. The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. USA 1996, 93, 9160-9165.
6. Pataer, A.; Vorburger, S. A.; Barber, G. N.; Chada, S.; Mhashilkar, A. M.; Zou-Yang, H.; Stewart, A. L.; Balachandran, S.; Roth, J. A.; Hunt, K. K.; Swisher, S. G. Adenoviral transfer of the melanoma differentiation-associated gene-7 (mda-7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. 2002, 62, 2239-2243. (Pubitemid 34411697)
7. Gopalan, B.; Litvak, A.; Sharma, S.; Mhashilkar, A. M.; Chada, S.; Ramesh, R. Activation of the Fas-FasL signaling pathway by mda-7=IL-24 kills human ovarian cancer cells. Cancer Res. 2005, 65, 3017-3024. (Pubitemid 40524577)
8. Lebedeva, I. V.; Sauane, M.; Gopalkrishnan, R. V.; Sarkar, D.; Su, Z. Z.; Gupta, P.; Nemunaitis, J.; Cunningham, C.; Yacoub, A.; Dent, P.; Fisher, P. B. mda-7=IL-24: Exploiting cancer's Achilles' heel. Mol. Ther. 2005, 11, 4-18. (Pubitemid 40011994)
9. Tong, A. W.; Nemunaitis, J.; Su, D.; Zhang, Y.; Cunningham, C.; Senzer, N.; Netto, G.; Rich, D.; Mhashilkar, A.; Parker, K.; Coffee, K.; Ramesh, R.; Ekmekcioglu, S.; Grimm, E. A.; van Wart Hood, J.; Merritt, J.; Chada, S. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7=IL24): Biologic outcome in advanced cancer patients. Mol. Ther. 2005, 11, 160-172. (Pubitemid 40012010)
10. Fisher, P. B. Is mda-7=IL-24 a ''magic bullet'' for cancer? Cancer Res. 2005, 65, 10128-10138.
11. Ramesh, R.; Mhashilkar, A. M.; Tanaka, F.; Saito, Y.; Branch, C. D.; Sieger, K.; Mumm, J. B.; Stewart, A. L.; Boquoi, A.; Dumoutier, L.; Grimm, E. A.; Renauld, J. C.; Kotenko, S.; Chada, S. Melanoma differentiation-associated gene-7=interleukin(IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res. 2003, 63, 5105-5113. (Pubitemid 37022651)
12. Su, Z. Z.; Lebedeva, I. V.; Sarkar, D.; Gopalkrishnan, R. V.; Sauane, M.; Sigmon, C.; Yacoub, A.; Valerie, K.; Dent, P.; Fisher, P. B. Melanoma differentiation associated gene-7, mda-7=IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 2003, 22, 1164-1180. (Pubitemid 36363380)
13. Su, Z.; Emdad, L.; Sauane, M.; Lebedeva, I. V.; Sarkar, D.; Gupta, P.; James, C. D.; Randolph, A.; Valerie, K.; Walter, M. R.; Dent, P.; Fisher, P. B. Unique aspects of mda-7=IL-24 antitumor bystander activity: Establishing a role for secretion of mda-7=IL-24 protein by normal cells. Oncogene 2005, 24, 7552-7566. (Pubitemid 41638030)
14. Jin, H.; Varner, J. Integrins: Roles in cancer development and as treatment targets. Br. J. Cancer 2004, 90, 561-565. (Pubitemid 38297190)
15. Kumar, C. C. Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis. Curr. Drug Targets 2003, 4, 123-131. (Pubitemid 36553584)
16. Zitzmann, S.; Ehemann, V.; Schwab, M. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor endothelial cells in vivo. Cancer Res. 2002, 62, 5139-5143. (Pubitemid 35024582)
17. Weber, W. A.; Haubner, R.; Vabuliene, E.; Kuhnast, B.; Wester, H. J.; Schwaiger, M. Tumor angiogenesis targeting using imaging agents. Q. J. Nucl. Med. 2001, 45, 179-182. (Pubitemid 32640393)
18. Liu, S. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Mol. Pharm. 2006, 3, 472-487. (Pubitemid 44639125)
19. Arap, W.; Pasqualini, R.; Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998, 279, 377-380. (Pubitemid 28063372)
20. Buckley, C. D.; Pilling, D.; Henriquez, N. V.; Parsonage, G.; Threlfall, K.; Scheel-Toellner, D.; Simmons, D. L.; Akbar, A. N.; Lord, J. M.; Salmon, M. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999, 397, 534-539.
21. Zarovni, N.; Monaco, L.; Corti, A. Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides. Hum. Gene Ther. 2004, 15, 373-382. (Pubitemid 38469779)
22. Eager, R.; Harle, L.; Nemunaitis, J. Ad-MDA-7; INGN 241: A review of preclinical and clinical experience. Expert Opin. Biol. Ther. 2008, 8, 1633-1643.
23. Sauane, M.; Gupta, P.; Lebedeva, I. V.; Su, Z. Z.; Sarkar, D.; Randolph, A.; Valerie, K.; Gopalkrishnan, R. V.; Fisher, P. B. N-Glycosylation of MDA-7=IL-24 is dispensable for tumor cell-specific apoptosis and ''bystander'' antitumor activity. Cancer Res. 2006, 66, 11869-11877. (Pubitemid 46094199)
24. Mhashilkar, A. M.; Stewart, A. L.; Sieger, K.; Yang, H. Y.; Khimani, A. H.; Ito, I.; Saito, Y.; Hunt, K. K.; Grimm, E. A.; Roth, J. A.; Meyn, R. E.; Ramesh, R.; Chada, S. MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol. Ther. 2003, 8, 207-219. (Pubitemid 37062831)
25. Lebedeva, I. V.; Su, Z. Z.; Sarkar, D.; Fisher, P. B. Restoring apoptosis as a strategy for cancer gene therapy: Focus on p53 and mda-7. Semin. Cancer Biol. 2003, 13, 169-178. (Pubitemid 36315934)